aclacinomycin has been researched along with abt-199 in 1 studies
| Studies (aclacinomycin) | Trials (aclacinomycin) | Recent Studies (post-2010) (aclacinomycin) | Studies (abt-199) | Trials (abt-199) | Recent Studies (post-2010) (abt-199) |
|---|---|---|---|---|---|
| 168 | 8 | 21 | 1,483 | 150 | 1,469 |
| Protein | Taxonomy | aclacinomycin (IC50) | abt-199 (IC50) |
|---|---|---|---|
| Apoptosis regulator Bcl-2 | Homo sapiens (human) | 0.0392 | |
| Bcl-2-like protein 1 | Homo sapiens (human) | 0.0667 | |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | Homo sapiens (human) | 0.0044 | |
| Aspartyl/asparaginyl beta-hydroxylase | Homo sapiens (human) | 1.445 | |
| Bcl-2-related protein A1 | Homo sapiens (human) | 0.0044 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, J; Li, J; Yu, W; Zhang, X | 1 |
1 other study(ies) available for aclacinomycin and abt-199
| Article | Year |
|---|---|
Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen.
Topics: Aclarubicin; Adult; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bridged Bicyclo Compounds, Heterocyclic; Combined Modality Therapy; Cytarabine; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Homoharringtonine; Humans; Male; Mutation; Neoplasm Proteins; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Sulfonamides | 2020 |